The reported world experience with liver transplant for carcinoid indicates that the outcome in general is as good but no better than that resulting from the best combination of multimodality treatment ( i.e. Octreotide/Sandostatin, Hepatic Artery Chemoembolization, Alpha interferon, tumor debulking by surgical excision, RFA, cryoablation, systemic chemotherapy and supportive measures). The rare exceptions when liver transplant is better are in those few cases with severe carcinoid syndrome unresponsive to Sandostatin with tumors restricted to the liver or in young patients with extensive tumors in the liver only and no tumors elsewhere.
